The Liberia-United States Joint Clinical Research Partnership has declared the begin of an Ebola Natural History Study at the J.F.K Medical Hospital in Sinkor, Monrovia.
As indicated by a press discharge, the study, code-named PREVAIL III, will research the mixture of wellbeing issues confronted by Ebola survivors and furnish study members with referral to other social insurance offices in the nation with the expectation of complimentary treatment.
Win III is intended to better comprehend what wellbeing issues Ebola survivors experience and to figure out if these conditions are the same or unique in relation to wellbeing issues individuals who have recouped from different genuine illnesses may have encountered.
The release said researchers will also examine whether those, who survived Ebola can transmit Ebola infection to their household contacts or sexual partners, and if so, whether these people get sick with Ebola. Lastly, the study will help to determine if people who survived the Ebola are “immune” or protected from getting Ebola in the future.
“The clinical consequences of surviving the deadly virus disease are a black box with many unknowns,” said Dr. Mosoka Fallah, Principal Investigator for the study and former Ebola Emergency-Response Consultant for Action Contre la Faim – Liberia.
“The study will unravel these unknowns so that optimized clinical care can be provided to survivors while at the same time preparing Liberia and the entire world with the effective prevention and treatment tools for the next Ebola outbreak,” he added.
The release added that the Natural History Study protocol has been approved by the Liberian Ethics and Scientific Review Committee, which reviews human research studies to protect the rights and welfare of the people taking part in those studies; and a scientific and ethics committee known as the Institutional Review Board at the U.S. National Institutes of Health or NIH.
The study is expected to enroll approximately 7,500 people, including 1,500 Ebola survivors and 6,000 of their close contacts.
“This is a major victory for our heroes (survivors) and for public health in general because the results from this study will help to address issues arising from future outbreaks”, said Deputy Health Minister and head of Liberia’s Ebola Incident Management System, Tolbert Nyenswah.